ArticleAntimicrobial agents and chemotherapy2016

Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.

Allison M Stickles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.